Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 1 Neoplasms 1 Diabetes Mellitus, Type 2 1

Interventions

pembrolizumab 16 Bevacizumab 11 Carboplatin 10 Nivolumab 8 Pemetrexed 7 Temozolomide 6 atezolizumab 5 Standard of Care 5 Prednisone 5 Exercise 5 Cyclophosphamide 5 Cetuximab 5 durvalumab 4 abemaciclib 4 Paclitaxel 4 Dexamethasone 4 Cisplatin 4 Blood Specimen Collection 4 dostarlimab 3 daratumumab 3 cabozantinib 3 Rituximab 3 Oxaliplatin 3 Metformin 3 Leucovorin 3 Lenalidomide 3 Ipilimumab 3 Fluorouracil 3 Doxorubicin 3 Docetaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Insulin × 30 days × Clear all

NCT07628556 2026-06-05

Antidiabetic Medications and Risk of Cancer

University of Pecs

74,799 enrolled

Diabetes Mellitus, Type 2, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡